# Ring Therapeutics: Research, Cambridge, United States

> Ring Therapeutics: Ring Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.

Source: https://millionrounds.com/startup/ring-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Ring Therapeutics

Ring Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.

Funding reported Last round: Series C

Research Cambridge, United States

Company summary

- **Founded:** 2017 9 years old
- **Team:** 43 11 to 50 people
- **Funding reported:** $254M in dollars
- **Last round:** Series C Mar 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Ring Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Ring Therapeutics

Ring Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 by Flagship Pioneering.

The company focuses on advancing gene therapy through its proprietary AnellogyTM platform, which utilizes engineered anelloviruses from the human commensal virome to create programmable genetic medicines. This innovative approach aims to develop life-saving, redosable, and tissue-specific therapies that address the limitations of current gene therapy methods. The primary product of Ring Therapeutics is AnellovectorsTM, a novel gene therapy vector platform designed for various therapeutic applications, including genetic disorders, ophthalmology, oncology, and metabolic disorders. The company has also developed AnelloBricks®, a biomanufacturing platform that enhances the production of Anellovectors. Ring Therapeutics serves the healthcare and life sciences sectors, providing advanced viral vector technologies to researchers and developers in the gene therapy field. With over $253 million in funding, including a recent Series C round, the company is well-positioned to continue its growth and innovation in gene therapy.

## What company datasets say Ring Therapeutics raised

Funding, as reported

Reported in all **$254M** in dollars

Rounds **3**

Last round **Series C**

Last round size **$87M**

Last round date **Mar 2023**

Investors listed **9**

## Founders and team

From Ring Therapeutics's own website: 3 on the team.

- **Chris McNulty** CEO
- **Christopher McNulty** CEO
- **Dmitriy Bobrovnikov** Chief Innovation Officer

## The company, in detail

What they build

Known for

gene therapy delivery health care injection routes biotechnology research manufacturing safety evaluation viral vector immune stealth immune evasion mechanisms vector engineering viral vector payload anellovector™ genetic defect repair gene delivery modular manufacturing therapeutic modalities medical research

Built with from their website

Google Tag Manager WordPress.org PWA Font Awesome Viewport Meta Mimecast Network Solutions Varnish 10x Genomics Apple Business Manager

+8 more

Underscore.js Microsoft Exchange MySQL Microsoft 365 Apps & Services Mobile Friendly Open Graph jQuery Anthropic Claude

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 2834, 8731, 2836
- **Region:** Massachusetts
- **Part of:** Flagship Pioneering
- **Revenue:** $3.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ring-therapeutics)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Ring Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)